Mirabegron+ Solifenacin in pharma franchise in West Bengal

Mirabegron+ Solifenacin in PCD pharma franchise in Dispur

Mirabegron+ Solifenacin in top pharma company in Bhilai

Mirabegron+ Solifenacin in pcd pharma supplier in Rourkela

Mirabegron+ Solifenacin in phama franchise company in India
Mirabegron+ Solifenacin in phama distributor in Mangalore

Home/Products /mirabegron-50mg-solifenacin-5mg-tablet

About the Product

Description


Miratyle S 50/5 Tablet is a combination medication containing Mirabegron (50mg) and Solifenacin (5mg), designed to provide a comprehensive solution for the treatment of overactive bladder (OAB) symptoms. This formulation combines two different classes of medications, each contributing to the reduction of OAB symptoms, such as urinary urgency, frequency, and incontinence.

  • Mirabegron is a beta-3 adrenergic agonist that works by relaxing the bladder’s detrusor muscle, which increases bladder capacity and reduces the involuntary contractions that lead to urinary urgency.
  • Solifenacin is an antimuscarinic agent that helps by blocking certain receptors in the bladder, reducing muscle spasms and further relieving symptoms associated with OAB.

Together, these two active ingredients target different mechanisms in the bladder, offering enhanced symptom control for patients with OAB who need both muscle relaxation and inhibition of bladder spasms.

This combination therapy is particularly beneficial for patients who have not responded adequately to other OAB treatments or for those who experience multiple symptoms that require a more comprehensive approach. The combination of Mirabegron and Solifenacin provides a unique mechanism of action that helps achieve better control of bladder function and an improved quality of life for OAB sufferers.

Common side effects include: Dry mouth Constipation Blurred vision Headache Increased blood pressure Serious side effects are rare but may include: Urinary retention Cognitive disturbances Severe allergic reactions (rash, swelling, breathing difficulties) Consult your healthcare provider if any of these side effects become severe or persistent.

Treatment of overactive bladder (OAB) symptoms such as urinary urgency, frequency, and incontinence in adults. Ideal for patients who need dual therapy to manage OAB effectively.

Use under the supervision of a healthcare provider. Not recommended for individuals with uncontrolled hypertension or those with a history of urinary retention. May cause dizziness or blurred vision; exercise caution when performing tasks that require alertness. Regular monitoring of blood pressure and kidney function is recommended during treatment.

Store at room temperature (between 15°C and 25°C). Keep in a dry place, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Mirabegron 50mg + Solifenacin 5mg Tablet in the PCD pharma franchise market?

Mirabegron 50mg + Solifenacin 5mg Tablet has strong demand in the urology, nephrology, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on urinary health and overactive bladder management portfolios.

Why should medical distributors include Mirabegron 50mg + Solifenacin 5mg Tablet in their product range?

Medical distributors and agencies can benefit from growing demand for overactive bladder (OAB) management under medical supervision. Mirabegron 50mg is a beta-3 adrenergic receptor agonist that helps relax the bladder muscle and increase bladder storage capacity Solifenacin 5mg is an antimuscarinic agent that helps reduce involuntary bladder contractions Commonly prescribed for overactive bladder syndrome, urinary urgency, increased urinary frequency, and urge urinary incontinence The dual-action combination helps provide enhanced symptom control in patients requiring combination therapy Frequently used as a long-term treatment option for chronic urinary disorders Widely prescribed by urologists, nephrologists, gynecologists, and physicians This strengthens a comprehensive urology and urinary healthcare portfolio. Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet? Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Mirabegron 50mg + Solifenacin 5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers. What benefits do wholesalers get by partnering for this product? Wholesalers and medical agencies benefit from specialist-driven prescriptions, long-term therapy demand, repeat orders, reliable supply chain support, and attractive margins in the urology and specialty healthcare segment. How can I become a distributor or franchise partner for this product? Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Mirabegron 50mg + Solifenacin 5mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialist-driven prescriptions, long-term therapy demand, repeat orders, reliable supply chain support, and attractive margins in the urology and specialty healthcare segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.